The glucose intolerance found in ALS would compromise the whole vesicular traffic in muscle, leading both to a reduction in the autophagic flux, and in turn to an even more important decrease in GLUT4 concentration at the plasma membrane, progressively worsening muscular metabolic impairments. The gene discussed is SLC2A4; the disease is Glucose intolerance.